Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1400 of 5804
-
Could a daily shot slow PSP? new study tests long-term safety
Disease control CompletedThe study will be conducted by the Sponsor to evaluate Twelve-months Long-Term Safety and Efficacy of GV1001 (1.12 mg) administered subcutaneously as a treatment for Progressive Supranuclear Palsy(PSP). In 75 patients diagnosed with PSP Richardson(PSP-RS) or PSP-Parkinsonism (PSP…
Phase: PHASE2 • Sponsor: GemVax & Kael • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Tiny implant could ease glaucoma pressure
Disease control OngoingThe VividWhite Glaucoma Implant (VW-51) is a novel surgical implant designed to treat glaucoma. This study is a 12-month, 65-participant non-comparative multicentre study to assess the safety and effectiveness of the VW-51 implant.
Phase: NA • Sponsor: VividWhite Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a Tight-Control strategy tame lupus?
Disease control Recruiting nowMulticenter, national, two-armed cluster-randomized controlled trial to evaluate the effect of a treat-to-target (T2T) strategy in in systemic lupus erythematosus (SLE). 14 centers will be randomized 1:1 to T2T or standard of care. Per arm 303 patients with SLE who are not in rem…
Phase: NA • Sponsor: Heinrich-Heine University, Duesseldorf • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can smarter antibiotic choices curb superbugs in liver disease?
Disease control Recruiting nowStudy to comparing conventrional antibiotic strategies versus regimens guided by epidemiological surveillance in infected patients with cirrhosis.
Phase: PHASE4 • Sponsor: Eva Bonfill • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New PARP1 inhibitor IMP1734 enters human trials for advanced cancers
Disease control Recruiting nowThis study investigates the safety and tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of EIK1003 in participants with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New test aims to stop unnecessary antibiotics for respiratory infections
Diagnosis Recruiting nowThe purpose of this study is to evaluate overall changes in patient management and longer-term resource utilization between control and test arms, including (but not limited to) additional work-up (including other diagnostic tests and consults), antimicrobial treatments, disposit…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
New COPD inhaler shows promise in large trial
Disease control CompletedTo evaluate the efficacy and safety of HL231 Solution for Inhalation vs Ultibro in Chinese patients with moderate to very severe COPD
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New hope for dialysis patients: drug aims to stop blood pressure crashes
Symptom relief Recruiting nowCurrently, there is no medication available to adequately treat patients undergoing hemodialysis who are suffering from intradialytic hypotension (IDH). Medical interventions such as Trendelenburg positioning, saline bolus administration, reduction of ultrafiltration rate, interr…
Phase: PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could a low-dose drug help relieve chronic fatigue and Long-COVID?
Symptom relief ENROLLING_BY_INVITATIONThe goal of this observational study is to assess the clinical response and the effect of autophagy function in patients before, during and throughout oral low dose sirolimus (rapamycin) therapy. The main questions this study aims to answer are: * Does rapamycin reduce the overa…
Sponsor: Simmaron Research Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Bypass patients may avoid A-Fib with one extra cut
Prevention CompletedThis study is planned to evaluate the effect of left posterior pericardiotomy for the prevention of postoperative atrial fibrillation after coronary artery bypass grafting. Eligible patients will be randomized to be created or not to be created the left posterior pericardiotomy a…
Phase: NA • Sponsor: Seoul National University Hospital • Aim: Prevention
Last updated Jun 27, 2026 13:02 UTC
-
Blood test score may guide ovarian cancer treatment decisions
Knowledge-focused CompletedThis study aims to understand whether it is possible to predict the effectiveness of maintenance treatment with PARP inhibitors following first-line chemotherapy in ovarian cancer, and thus better target the patients who benefit from this treatment
Sponsor: ARCAGY/ GINECO GROUP • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New pill hopes to boost blood in bone marrow disease
Disease control OngoingThis research is being conducted to asses if HT-6184 is effective in the treatment of Very Low, Low, or Intermediate Risk Myelodysplastic Syndrome (MDS) and Symptomatic Anemia. The study includes a 28-day Screening Period followed by a 16- or 32-week Treatment Period. Participa…
Phase: PHASE2 • Sponsor: Halia Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
No more charging: new implant aims to ease bladder and bowel leaks
Disease control OngoingMulticenter, prospective, non randomized, single arm evaluation of patients with overactive bladder (OAB) and/or fecal incontinence (FI) employing the Axonics recharge free SNM System.
Phase: NA • Sponsor: Axonics, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New heart catheter shows promise for AFib patients
Disease control CompletedThe purpose of this study is to demonstrate safety and effectiveness of the Biosense Webster (BWI) ablation system (THERMOCOOL SMARTTOUCH surround flow \[STSF\] catheter and TRUPULSE generator) when used for isolation of the atrial pulmonary veins (PVs) in treatment of participan…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Could a common cholesterol drug slow liver scarring?
Disease control Recruiting nowThis is a double-blind, phase 2 study to evaluate safety and efficacy of rosuvastatin in comparison to placebo after 2 years in patients with compensated cirrhosis.
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Kidney ultrasound may help keep heart rhythm steady after second AFib procedure
Disease control Recruiting nowThis is a Prospective, controlled, single-blind, randomized (2:1, Intervention:Control) clinical trial. The purpose of the study is to determine the role of adjunctive renal sympathetic denervation in the prevention of Atrial Fibrillation (AF) recurrence in patients with hyperten…
Phase: NA • Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Blood pressure drug joins forces with immunotherapy and radiation to fight head and neck cancer
Disease control Recruiting nowThis phase Ib trial tests the safety, side effects and how well losartan, pembrolizumab and stereotactic body radiation therapy (SBRT) for the treatment of patients with head and neck squamous cell carcinoma that has come back to nearby tissue or lymph node after a period of impr…
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Lupus drug may shield heart and arteries
Disease control Recruiting nowBackground: People with systemic lupus erythematosus (SLE) are at risk of developing complications in their blood vessels. This can increase the risk of heart attacks or stroke. No medications have been effective at reducing this risk in people with lupus. Objective: To test w…
Phase: PHASE2 • Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug cocktail targets Hard-to-Treat colon cancer mutation
Disease control OngoingTo find the recommended dose of MRTX849 that can be given in combination with cetuximab and irinotecan to patients with colorectal cancer that have a mutation (genetic change) called KRAS G12C.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Spinal stimulation showdown: which technique helps paralyzed patients stand?
Knowledge-focused Recruiting nowIt has been demonstrated that the human lumbosacral spinal cord can be neuromodulated with epidural (ESS) and transcutaneous (TSS) spinal cord stimulation to enable recovery of standing and volitional control of the lower limbs after complete motor paralysis due to spinal cord in…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC